Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polybenzyl derivative, drug composition thereof and preparation method and application of drug composition

A technology of polybenzyl derivatives and compositions, which is applied in the field of medicine and can solve the problems of no biological activity, no reports and reports of polybenzyl derivatives, etc.

Active Publication Date: 2019-05-28
KUNMING INST OF BOTANY - CHINESE ACAD OF SCI
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There is no report about polybenzyl derivatives 1-12 in the prior art, nor is there any report about its biological activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polybenzyl derivative, drug composition thereof and preparation method and application of drug composition
  • Polybenzyl derivative, drug composition thereof and preparation method and application of drug composition
  • Polybenzyl derivative, drug composition thereof and preparation method and application of drug composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Compound 1-6 separation and purification:

[0027] Partial extraction and separation from ethyl acetate of Gastrodia elata. Fresh Gastrodia elata (45.0kg) slices were soaked in 90% ethanol for three times, filtered, the residue was soaked in 50% ethanol for three times and filtered, the residue was boiled once, all the filtrates were combined, and concentrated under reduced pressure until alcohol-free. Extract with ethyl acetate 3 times, obtain ethyl acetate extraction part (102g), water phase is through macroporous resin, water, 50% ethanol and 90% elution respectively, obtain water part (1.6kg), 50% ethanol (71g ), 90% (8g). Mix 88g of sample with 88g of silica gel, and use 880g of silica gel for wet packing. with EtOAc:CHCl 3 The system was eluted at 0:100, 5:95, 10:90, 20:80, 40:60, and MeOH, and 5 fractions were obtained. Guided by activity tracking, the active part and the inactive part were separated and purified, as shown in the table 2 is the test results o...

Embodiment 2

[0060] Compounds 1-12 on melatonin receptor MT 1 and MT 2 Agonistic activity of the receptor.

[0061] 1 Materials and methods

[0062] 1.1 Materials:

[0063] melatonin receptor MT 1 and MT 2 The cell lines used for agonistic activity screening correspond to human kidney epithelial cells HEK293-MT 1 and HEK293-MT 2 ; Cell culture medium (Dulbecco's Modified Eagle Medium, DMEM) containing 10% fetal bovine serum; No-wash calcium flow kit.

[0064] 1.2 Instrument: CO 2 Constant temperature incubator Thermo Forma 3310 (USA); Inverted biological microscope XD-101 (Nanjing); Flexstation 3 Benchtop Multi-Mode Microplate Reader (Molecular Devices, Sunnyvale, California, USA).

[0065] 1.3 Experimental process

[0066] Coat the 96-well black-walled transparent-bottom cell culture plate with the substrate BD Matrigel, put it in a constant temperature incubator at 37°C for 1 hour, absorb the supernatant, and dilute it with 4×10 4 Density per well, the corresponding HEK293 cell...

preparation Embodiment

[0076] 1. Compound 1-12 was prepared according to the method of Example 1. After dissolving with a small amount of DMSO, water for injection was added as usual, finely filtered, potted and sterilized to make an injection.

[0077] 2. Compound 1-12 was prepared according to the method of Example 1. After dissolving with a small amount of DMSO, it was dissolved in sterile water for injection, stirred to dissolve, filtered with a sterile suction filter funnel, and then sterile finely filtered. Packed in ampoules, freeze-dried at low temperature and sealed aseptically to obtain powder injection.

[0078] 3. According to the method of Example 1, the compound 1-12 was firstly prepared, and the excipient was added according to the weight ratio of the compound 1-12 to the excipient at a ratio of 9:1 to make a powder.

[0079] 4. According to the method of Example 1, the compound 1-12 was firstly prepared, and the excipient was added according to the weight ratio of the compound 1-12 t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a polybenzyl derivative (1-12) shown as a structural formula (I) or a drug composition of the polybenzyl derivative (1-12), a preparation method of the drug composition, and application of the drug composition to preparation of a melatonin receptor agonist and preparation of drugs for treating or preventing central nervous system diseases related to melatonin receptors.

Description

Technical field: [0001] The invention belongs to the technical field of medicines. Specifically, it relates to derivatives (1-12) of phenolic compound polybenzyl (1-12) or pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof, which are used as melatonin receptor agonists, and are used in the preparation of treatment or prevention of melatonin Drug application in the central nervous system diseases related to hormone receptors. Background technique [0002] Melatonin (N-acetyl-5-methoxytryptamine, Melatonin) is an amine hormone mainly produced by the pineal gland in the human body. It was first isolated from bovine pineal tissue by Lerner et al. in 1958. The production of melatonin is mainly through the conversion of L-tryptophan into 5-hydroxytryptamine in pineal cells, and then generates N-acetyl 5-hydroxytryptamine under the action of N-acetyltransferase (AA-NAT), and finally in 5-hydroxytryptamine. Melatonin is produced by the enzyme oxindo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C43/23C07C43/178C07C41/34C07C213/00C07C215/76C07C319/14C07C323/20C07H1/00C07H15/203A61K31/085A61K31/075A61K31/136A61K31/10A61K31/7034A61P25/00
Inventor 陈纪军陈思月耿长安马云保黄晓燕张雪梅
Owner KUNMING INST OF BOTANY - CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com